glp-1 drug delivery devices Navigating use in therapy GLP-1s: What They Are and

In rare cases, more serious complications like intestinal obstruction have been reported in FDA labeling for some of these medications

This is another major differentiator from insulin

The study utilized a single-blind, randomized, placebo-controlled, crossover design, combined with functional magnetic resonance imaging (fMRI), to analyze the performance of 54 participants (30 with normal insulin sensitivity and 24 with impaired insulin sensitivity) on sensory associative learning tasks while receiving liraglutide and placebo treatments

There are evidence that microglial cells also secrete GLP-1 in mice

10.3389/fendo.2019.00080 39 DeFronzoR

22 Variations in formulation, dosing schedules, and dual agonism with tirzepatide influence tolerability, emphasizing the need for individualized therapy